Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (NUMIF)

Numinus Wellness Inc (NUMIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
Numinus Wellness Provides Corporate Update

Numinus sharpens its focus on streamlining operations and maximizing shareholder returns through a focus on U.S. operations and strategic adjustments in its...

NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Q2 Fiscal 2024 Highlights Cash position of $6.6 million as of February 29, 2024 Gross profit of $0.5 million, a 22.7% decline over Q1 2024 Revenue of $5.0...

NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)
Numinus Wellness Submits Clinical Trial Application

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
Numinus Wellness Provides Corporate Update

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

MNMD : 8.52 (+0.71%)
NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 7.86 (-2.96%)
SEEL : 0.2856 (-5.12%)
ATAI : 1.8400 (-1.60%)
MNMD : 8.52 (+0.71%)
NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 7.86 (-2.96%)
SEEL : 0.2856 (-5.12%)
ATAI : 1.8400 (-1.60%)
MNMD : 8.52 (+0.71%)
NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)
Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar